Showing results (141-150 of 261) with videos related to

Sort By:
Pageof 27
European Journal of Public Health|October 31, 2019
Cost-utility analysis of lifestyle interventions to prevent type 2 diabetes in women with prior gestational diabetesAmber Werbrouck, Masja Schmidt, Koen Putman, et al.
International Journal of Public Health|April 29, 2014
Risk factor awareness in a coronary population and the association with health-related quality of life outcomesDelphine De Smedt, Els Clays, Lieven Annemans, et al.
Revista Espanola De Cardiologia|August 30, 2006
[Health economic evaluation of low-dose acetylsalicylic acid in the primary prevention of cardiovascular disease]Mark Lamotte, Carme Piñol, Carlos Brotons, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|September 27, 2006
How to improve screening in first-degree relatives of patients with premature coronary heart diseaseLieve Debruyne, Dirk De Bacquer, Stefaan De Henauw, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|August 23, 2018
Endovascular Training Using a Simulation Based Curriculum is Less Expensive than Training in the Hybrid AngiosuiteHeidi Maertens, Frank Vermassen, Rajesh Aggarwal, et al.
BMC Health Services Research|August 25, 2010
Systematic review: Effects, design choices, and context of pay-for-performance in health carePieter Van Herck, Delphine De Smedt, Lieven Annemans, et al.
The International Journal on Drug Policy|April 27, 2017
Economic consequences of legal and illegal drugs: The case of social costs in BelgiumDelfine Lievens, Freya Vander Laenen, Nick Verhaeghe, et al.
BMC Public Health|August 20, 2014
Cost-effectiveness of health promotion targeting physical activity and healthy eating in mental health careNick Verhaeghe, Delphine De Smedt, Jan De Maeseneer, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|October 3, 2012
Cost-effectiveness of vaccinating adults with the 23-valent pneumococcal polysaccharide vaccine (PPV23) in GermanyYiling Jiang, Aline Gauthier, Lieven Annemans, et al.
Pageof 27